NCT03608826View on ClinicalTrials.gov

Relationship Between LINQ™ Subcutaneous Impedance and Right-sided Hemodynamic Measurements

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 13, 2018

Primary Completion Date

May 7, 2021

Study Completion Date

May 7, 2021

Conditions
Heart Failure
Interventions
DEVICE

Investigational LINQ™ HF RAMware

The Reveal LINQ™ device and the 2090 programmer are market-released, but once the investigational LINQ™ HF RAMware is downloaded into the devices, they are considered investigational.

Trial Locations (1)

43210

Ohio State University, Columbus

All Listed Sponsors
lead

Medtronic Cardiac Rhythm and Heart Failure

INDUSTRY

NCT03608826 - Relationship Between LINQ™ Subcutaneous Impedance and Right-sided Hemodynamic Measurements | Biotech Hunter | Biotech Hunter